More studies are needed to verify the oncogenic role and potential mechanism of OIP5 in ccRCC, and more cohorts are needed to improve the predictive accuracy then help the personalized management of ccRCC patients. This evidence concerns the gene OIP5 and nonpapillary renal cell carcinoma.